476 related articles for article (PubMed ID: 21920711)
1. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
Friedman ES; Davis LL; Zisook S; Wisniewski SR; Trivedi MH; Fava M; Rush AJ;
Eur Neuropsychopharmacol; 2012 Mar; 22(3):183-99. PubMed ID: 21920711
[TBL] [Abstract][Full Text] [Related]
2. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
3. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
Bobo WV; Chen H; Trivedi MH; Stewart JW; Nierenberg AA; Fava M; Kurian BT; Warden D; Morris DW; Luther JF; Husain MM; Cook IA; Lesser IM; Kornstein SG; Wisniewski SR; Rush AJ; Shelton RC
J Affect Disord; 2011 Oct; 133(3):467-76. PubMed ID: 21601287
[TBL] [Abstract][Full Text] [Related]
5. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.
Rush AJ; Trivedi MH; Stewart JW; Nierenberg AA; Fava M; Kurian BT; Warden D; Morris DW; Luther JF; Husain MM; Cook IA; Shelton RC; Lesser IM; Kornstein SG; Wisniewski SR
Am J Psychiatry; 2011 Jul; 168(7):689-701. PubMed ID: 21536692
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.
Jha MK; Minhajuddin A; Gadad BS; Greer TL; Mayes TL; Trivedi MH
Brain Behav Immun; 2017 Nov; 66():103-110. PubMed ID: 28698115
[TBL] [Abstract][Full Text] [Related]
7. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ;
Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
[TBL] [Abstract][Full Text] [Related]
8. Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial.
Jha MK; Wakhlu S; Dronamraju N; Minhajuddin A; Greer TL; Trivedi MH
J Affect Disord; 2018 Jul; 234():34-37. PubMed ID: 29522941
[TBL] [Abstract][Full Text] [Related]
9. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
10. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
Warden D; Trivedi MH; Carmody T; Toups M; Zisook S; Lesser I; Myers A; Kurian KR; Morris D; Rush AJ
J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
[TBL] [Abstract][Full Text] [Related]
11. Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
Chekroud AM; Gueorguieva R; Krumholz HM; Trivedi MH; Krystal JH; McCarthy G
JAMA Psychiatry; 2017 Apr; 74(4):370-378. PubMed ID: 28241180
[TBL] [Abstract][Full Text] [Related]
12. Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.
Jha MK; Minhajuddin A; Gadad BS; Greer T; Grannemann B; Soyombo A; Mayes TL; Rush AJ; Trivedi MH
Psychoneuroendocrinology; 2017 Apr; 78():105-113. PubMed ID: 28187400
[TBL] [Abstract][Full Text] [Related]
13. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Rush AJ; Trivedi MH; Wisniewski SR; Stewart JW; Nierenberg AA; Thase ME; Ritz L; Biggs MM; Warden D; Luther JF; Shores-Wilson K; Niederehe G; Fava M;
N Engl J Med; 2006 Mar; 354(12):1231-42. PubMed ID: 16554525
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
Sung SC; Wisniewski SR; Luther JF; Trivedi MH; Rush AJ;
J Affect Disord; 2015 Mar; 174():157-64. PubMed ID: 25497473
[TBL] [Abstract][Full Text] [Related]
15. Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial.
Jha MK; Malchow AL; Grannemann BD; Rush AJ; Trivedi MH
Neuropsychopharmacology; 2018 Oct; 43(11):2197-2203. PubMed ID: 30135556
[TBL] [Abstract][Full Text] [Related]
16. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
Fava M; Rush AJ; Wisniewski SR; Nierenberg AA; Alpert JE; McGrath PJ; Thase ME; Warden D; Biggs M; Luther JF; Niederehe G; Ritz L; Trivedi MH
Am J Psychiatry; 2006 Jul; 163(7):1161-72. PubMed ID: 16816220
[TBL] [Abstract][Full Text] [Related]
17. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
18. Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
Davis LL; Pilkinton P; Wisniewski SR; Trivedi MH; Gaynes BN; Howland RH; Zisook S; Balasubramani GK; Fava M; Rush AJ
Depress Anxiety; 2012 Feb; 29(2):111-22. PubMed ID: 22495941
[TBL] [Abstract][Full Text] [Related]
19. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
[TBL] [Abstract][Full Text] [Related]
20. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]